---
title: Emerging drugs in phase II and III clinical development for the treatment of
  alcohol use disorder
date: '2024-04-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38606899/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240412180741&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Alcohol Use Disorder (AUD) poses an ongoing significant
  global health burden. AUD is highly prevalent and affects not only the individuals
  with AUD, but also their communities and society at large. Even though pharmacotherapy
  is an integral part of AUD treatment, the few available substances show limited
  efficacy and limited clinical impact. Thus, there is a need for new innovative pharmacotherapeutic
  ...'
disable_comments: true
---
INTRODUCTION: Alcohol Use Disorder (AUD) poses an ongoing significant global health burden. AUD is highly prevalent and affects not only the individuals with AUD, but also their communities and society at large. Even though pharmacotherapy is an integral part of AUD treatment, the few available substances show limited efficacy and limited clinical impact. Thus, there is a need for new innovative pharmacotherapeutic ...